Prophylaxis Against Thromboembolic Events During Chemotherapy for Germ Cell Cancer

INTRODUCTION: Patients with advanced germ cell tumors (GCT) receiving cisplatin-based chemotherapy have high rates of thromboembolic events (TEE) which can negatively affect their overall survival. While primary TEE prophylaxis during chemotherapy may prevent these events, it is unclear which patien...

Descripción completa

Detalles Bibliográficos
Autores principales: Meng, Xiaosong, Ahmed, Murtaza, Courtney, Kevin D., Arafat, Waddah, Ibrahim, Ibrahim, Margulis, Vitaly, Nichols, Craig, Bagrodia, Aditya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8529113/
https://www.ncbi.nlm.nih.gov/pubmed/34692501
http://dx.doi.org/10.3389/fonc.2021.724682

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8529113/
https://www.ncbi.nlm.nih.gov/pubmed/34692501
http://dx.doi.org/10.3389/fonc.2021.724682

Ejemplares similares